Login / Signup
Nabarun Chandra Das
ORCID
Publication Activity (10 Years)
Years Active: 2021-2023
Publications (10 Years): 7
Top Topics
Induced Pluripotent Stem Cells
Virtual Reality
Molecular Docking
Drug Administration
Top Venues
Antibodies (Basel, Switzerland)
Future virology
Advances in experimental medicine and biology
Journal of cellular and molecular medicine
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Nabarun Chandra Das
,
Pritha Chakraborty
,
Samapika Nandy
,
Abhijit Dey
,
Tadesse Asmamaw Dejenie
,
Suprabhat Mukherjee
Programmed cell death pathways as targets for developing antifilarial drugs: Lessons from the recent findings.
Journal of cellular and molecular medicine
(2023)
Nabarun Chandra Das
,
Pritha Chakraborty
,
Jagadeesh Bayry
,
Suprabhat Mukherjee
Comparative Binding Ability of Human Monoclonal Antibodies against Omicron Variants of SARS-CoV-2: An In Silico Investigation.
Antibodies (Basel, Switzerland)
12 (1) (2023)
Nabarun Chandra Das
,
Pritha Chakraborty
,
Jagadeesh Bayry
,
Suprabhat Mukherjee
Comparative Binding Ability of Human Monoclonal Antibodies against Omicron Variants of SARS-CoV-2: An In Silico Investigation.
Antibodies (Basel, Switzerland)
12 (1) (2023)
Nabarun Chandra Das
,
Pritha Chakraborty
,
Jagadeesh Bayry
,
Suprabhat Mukherjee
Comparative Binding Ability of Human Monoclonal Antibodies against Omicron Variants of SARS-CoV-2: An In Silico Investigation.
Antibodies (Basel, Switzerland)
12 (1) (2023)
Bhabani Shankar Das
,
Nabarun Chandra Das
,
Shasanka Sekhar Swain
,
Suprabhat Mukherjee
,
Debapriya Bhattacharya
Andrographolide induces anti-SARS-CoV-2 response through host-directed mechanism: an in silico study.
Future virology
(2022)
Ritwik Patra
,
Nabarun Chandra Das
,
Suprabhat Mukherjee
Toll-Like Receptors (TLRs) as Therapeutic Targets for Treating SARS-CoV-2: An Immunobiological Perspective.
Advances in experimental medicine and biology
1352 (2022)
Nabarun Chandra Das
,
Anindya Sundar Ray
,
Jagadeesh Bayry
,
Suprabhat Mukherjeee
Therapeutic Efficacy of Anti-Bestrophin Antibodies against Experimental Filariasis: Immunological, Immune-Informatics and Immune Simulation Investigations.
Antibodies (Basel, Switzerland)
10 (2) (2021)